Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

July 13, 2020

Correspondence response
Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?’ by Marques et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace

doi: 10.1136/annrheumdis-2020-218431
Correspondence
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
Free

Claudia Marques, Marcelo M Pinheiro, Edgard Torres Reis Neto, Andrea Tavares Dantas, Francinne Machado Ribeiro, Ana Karla G Melo

doi: 10.1136/annrheumdis-2020-218388

July 10, 2020

Correspondence
‘Halo Score’: missing large-vessel giant cell arteritis— do we need a ‘modified Halo Score’?
Free

Arghya Chattopadhyay, Alakendu Ghosh

doi: 10.1136/annrheumdis-2020-218224
Correspondence response
Response to: ‘‘Halo Score’: missing large vessel giant cell arteritis– do we need a modified ‘Halo Score?’’ by Chattopadhyay and Ghosh
Free

Kornelis S M van der Geest, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2020-218262

July 09, 2020

Correspondence
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
Free

Pedro Santos-Moreno, Diana Buitrago-Garcia, Laura Villarreal, Anggie Aza, Michael Cabrera, Wilberto Rivero, Adriana Rojas-Villarraga

doi: 10.1136/annrheumdis-2020-218259

July 06, 2020

Correspondence
Should patients starting biologics be screened for COVID-19?
Free

Jesus Alberto Cardenas-de la Garza, Rosa I Arvizu-Rivera, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2020-218437
Correspondence
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Free

Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi

doi: 10.1136/annrheumdis-2020-218214

July 03, 2020

Correspondence response
Response to: ‘Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still’s disease’ by Ruscitti et al
Free

Claudia Kedor, Joachim Listing, Jan Zernicke, Eugen Feist

doi: 10.1136/annrheumdis-2020-218143

July 02, 2020

Correspondence
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Free

Neus Quilis, Paloma Vela, Boris A Blanco Cáceres, Cesar Diaz-Torne, Enrique Calvo-Aranda, Francisca Sivera, Alejandro Prada-Ojeda, Fernando Pérez Ruiz, Eliseo Pascual, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218226
Correspondence response
Response to: ‘Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland’ by Quills et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218263

July 01, 2020

Correspondence response
Evaluating diagnostic criteria for macrophage activation syndrome in patients with adult onset Still’s disease. Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2020-218033

June 26, 2020

Correspondence
Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease
Free

Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2020-218124
Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease’ by Akiyama et al
Free

Augusto Vaglio, Federica Maritati, Jochen Zwerina

doi: 10.1136/annrheumdis-2020-218174

June 25, 2020

Correspondence response
Is a human in vitro enthesitis model relevant to SpA-associated enthesitis? Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al
Free

Abdulla Watad, Hannah Rowe, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

doi: 10.1136/annrheumdis-2020-218151
Correspondence
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
Free

Vega Jovani, Irene Calabuig, Maria Luisa Peral-Garrido, Ernesto Tovar-Sugrañes, María-del-Carmen López-González, Pilar Bernabeu, Agustín Martínez, Joaquim Esteve-Vives, Jose-Manuel León-Ramírez, Oscar Moreno-Perez, Vicente Boix, Joan Gil, Esperanza Merino, Paloma Vela, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218152
Correspondence response
Response to: ‘Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors’ by Jovani et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary S Wallace

doi: 10.1136/annrheumdis-2020-218179

June 24, 2020

Correspondence
Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al
Free

Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Murat Torgutalp, Hildrun Haibel, Janis Lucas Vahldiek, Ann-Christin von Brünneck, Safwan Omran, Denis Poddubnyy, Fabian Proft

doi: 10.1136/annrheumdis-2020-217894
Correspondence response
Response to: ‘Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al’ by Rios Rodriguez et al
Free

Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita

doi: 10.1136/annrheumdis-2020-218055

June 22, 2020

Correspondence response
Response to: ‘Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues’ by Ghajari and Sabour
Free

Kornelis SM van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2020-218144
Correspondence
Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues
Free

Hadis Ghajari, Siamak Sabour

doi: 10.1136/annrheumdis-2020-218038

June 19, 2020

Correspondence
Understanding bone fragility: theoretical explanation to non-physician health professionals
Free

Toshihiro Sugiyama

doi: 10.1136/annrheumdis-2020-218003
Correspondence response
Response to: ‘Understanding bone fragility: theoretical explanation to non-physician health professionals’ by Sugiyama
Free

Jo Adams, Nicky Wilson, Tanja A Stamm

doi: 10.1136/annrheumdis-2020-218049
Correspondence
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Free

Kevin Sheng-Kai Ma, James Cheng-Chung Wei, Wen-Hung Chung

doi: 10.1136/annrheumdis-2020-218090
Correspondence response
Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: ‘Confunding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’’ by Hsu et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218150
Correspondence
Confounding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Free

Po-Ke Hsu, Yung-Heng Lee, James Cheng Chung Wei

doi: 10.1136/annrheumdis-2020-218056
Correspondence response
Allopurinol versus febuxostat hypersensitivity reactions in the US elderly: differences in study outcomes and populations. Response to: ‘Correspondence to “Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’ by Ma et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218149

June 12, 2020

Correspondence
Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications
Free

Vincenzo L'Imperio, Gisella Vischini, Fabio Pagni, Pietro Manuel Ferraro

doi: 10.1136/annrheumdis-2020-217979
Correspondence
Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease
Free

Alessia Alunno, Onelia Bistoni, Roberto Gerli

doi: 10.1136/annrheumdis-2020-218094
Correspondence response
Selection of appropriate outcome measure in ANCA-associated vasculitis. Response to: ‘Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’ by L'Imperio et al
Free

Dilek Solmaz, Servet Akar

doi: 10.1136/annrheumdis-2020-218035

June 11, 2020

Correspondence
Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome
Free

Wenhui Xie, Hong Huang, Zhuoli Zhang

doi: 10.1136/annrheumdis-2020-217854
Correspondence response
Response to: ‘Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome’ by Xie et al
Free

Yueting Li, Yihan Cao, Chen Li, Wen Zhang

doi: 10.1136/annrheumdis-2020-217956

June 08, 2020

Correspondence
Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist
Free

Andrea Becciolini, Alarico Ariani, Marco Becciolini

doi: 10.1136/annrheumdis-2020-217980
Correspondence response
Which joints and what pathological findings should be evaluated on ultrasound in CCP+ at-risk individuals? The fifth MTP joint for bone erosions is a good starting point. Response to: ‘Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist’ by Becciolini et al
Free

Andrea Di Matteo, Kulveer Mankia, Richard J Wakefield, Paul Emery

doi: 10.1136/annrheumdis-2020-218036

May 29, 2020

Correspondence
Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population
Free

Xanthe M E Matthijssen, Tom W J Huizinga, Annette H M van der Helm-van Mil

doi: 10.1136/annrheumdis-2020-217609
Correspondence response
The positive correlation between Porphyromonas gingivalis and Prevotella spp. Response to: ‘Comment on ‘Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population’ by Kishikawa et al.’ by Kitamura et al
Free

Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Yukinori Okada

doi: 10.1136/annrheumdis-2020-217897
Correspondence response
Response to: ‘Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population’ by Matthijssen et al
Free

Elena Myasoedova, John Davis, Eric L Matteson, Cynthia S Crowson

doi: 10.1136/annrheumdis-2020-217900
Correspondence
Comment on: ‘Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population’ by Kishikawa et al
Free

Kaori Kitamura, Hiroshi Shionoya, Kuniaki Terato, Suguru Suzuki, Richio Fukai, Shinichi Uda, Chiyuki Abe, Hiromitsu Takemori, Keita Nishimura, Hisashi Baba, Takaki Waritani, Kou Katayama

doi: 10.1136/annrheumdis-2020-217808

May 28, 2020

Correspondence response
Relationship between rheumatoid arthritis and interstitial lung disease is a ‘two-way street’. Response to: ‘Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach’ by Alunno et al
Free

Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, Isabel Haro, Raimon Sanmarti

doi: 10.1136/annrheumdis-2020-217432
Correspondence
‘Finding the right one’
Free

Abhishek Arvind Zanwar

doi: 10.1136/annrheumdis-2020-217731
Correspondence response
Response to: ‘Finding the right one’ by Zanwar
Free

Thomas Renson, Filip E Van den Bosch, Dirk Elewaut

doi: 10.1136/annrheumdis-2020-217856

May 27, 2020

Correspondence response
Response to: ‘Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?’ by Chessa et al
Free

Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour, Cynthia Aranow

doi: 10.1136/annrheumdis-2020-217692
Correspondence response
Response to: ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked’ by Safiri and Mansournia
Free

Zhi-Hao Li, Qing-Mei Huang, Chen Mao

doi: 10.1136/annrheumdis-2020-217896
Correspondence
Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked
Free

Saeid Safiri, Mohammad Ali Mansournia

doi: 10.1136/annrheumdis-2020-217732
Correspondence
Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?
Free

Elisabetta Chessa, Matteo Piga, Laurent Arnaud

doi: 10.1136/annrheumdis-2020-217632

May 20, 2020

Correspondence
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus
Free

Chia-Ying Wu, Magdalene Tan, Jing-Yang Huang, Jeng-Yuan Chiou, James Cheng-Chung Wei

doi: 10.1136/annrheumdis-2020-217728

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

July 22, 2020

July 21, 2020

July 15, 2020

July 13, 2020

July 10, 2020

July 09, 2020

July 06, 2020

July 03, 2020

July 02, 2020

July 01, 2020

June 26, 2020

June 25, 2020

June 24, 2020

June 22, 2020

June 19, 2020

June 12, 2020

June 11, 2020

June 08, 2020

May 29, 2020

May 28, 2020

May 27, 2020

May 20, 2020

Pages